

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA double-strand break processing (GO:0000729) | 5.27878831 |
| 2 | proteasome assembly (GO:0043248) | 5.02544107 |
| 3 | keratinocyte development (GO:0003334) | 4.04571730 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.98454894 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 3.88397590 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 3.88397590 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.88397590 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.88397590 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.88397590 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 3.88397590 |
| 11 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.85013717 |
| 12 | histone exchange (GO:0043486) | 3.82089144 |
| 13 | mitotic sister chromatid cohesion (GO:0007064) | 3.76453405 |
| 14 | chromatin remodeling at centromere (GO:0031055) | 3.73646799 |
| 15 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.73440045 |
| 16 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 3.72068223 |
| 17 | isotype switching (GO:0045190) | 3.72068223 |
| 18 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 3.72068223 |
| 19 | CENP-A containing nucleosome assembly (GO:0034080) | 3.71382266 |
| 20 | leukocyte aggregation (GO:0070486) | 3.69801863 |
| 21 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.64849621 |
| 22 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.60161718 |
| 23 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.60161718 |
| 24 | positive regulation of interferon-alpha production (GO:0032727) | 3.55598411 |
| 25 | regulation of interferon-alpha production (GO:0032647) | 3.45321735 |
| 26 | hepatocyte apoptotic process (GO:0097284) | 3.44641842 |
| 27 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.43983822 |
| 28 | replication fork processing (GO:0031297) | 3.42477023 |
| 29 | somite rostral/caudal axis specification (GO:0032525) | 3.40715500 |
| 30 | phospholipid scrambling (GO:0017121) | 3.35766972 |
| 31 | ribosome assembly (GO:0042255) | 3.33830865 |
| 32 | regulation of mesoderm development (GO:2000380) | 3.31341948 |
| 33 | lactate metabolic process (GO:0006089) | 3.28639078 |
| 34 | cellular extravasation (GO:0045123) | 3.27144987 |
| 35 | DNA deamination (GO:0045006) | 3.23536271 |
| 36 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.18505040 |
| 37 | regulation of centriole replication (GO:0046599) | 3.15426698 |
| 38 | histamine secretion (GO:0001821) | 3.12459561 |
| 39 | platelet dense granule organization (GO:0060155) | 3.11880736 |
| 40 | mitotic G2/M transition checkpoint (GO:0044818) | 3.11616421 |
| 41 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.10241149 |
| 42 | anterior/posterior axis specification, embryo (GO:0008595) | 3.09751852 |
| 43 | neutrophil activation involved in immune response (GO:0002283) | 3.07451261 |
| 44 | histone mRNA catabolic process (GO:0071044) | 3.07439645 |
| 45 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.05950600 |
| 46 | intestinal epithelial cell development (GO:0060576) | 3.05423465 |
| 47 | response to X-ray (GO:0010165) | 3.03869236 |
| 48 | respiratory burst (GO:0045730) | 3.03407531 |
| 49 | negative regulation of cell killing (GO:0031342) | 3.02871558 |
| 50 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.02871558 |
| 51 | regulation of Rac protein signal transduction (GO:0035020) | 3.02717473 |
| 52 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.99926465 |
| 53 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.98082871 |
| 54 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.97307817 |
| 55 | female gonad development (GO:0008585) | 2.97186692 |
| 56 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.97003347 |
| 57 | regulation of helicase activity (GO:0051095) | 2.95263785 |
| 58 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.92312398 |
| 59 | endoderm formation (GO:0001706) | 2.92070589 |
| 60 | nodal signaling pathway (GO:0038092) | 2.91731121 |
| 61 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.90164231 |
| 62 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.88866136 |
| 63 | dorsal/ventral axis specification (GO:0009950) | 2.87538529 |
| 64 | zinc ion transport (GO:0006829) | 2.86734322 |
| 65 | genitalia morphogenesis (GO:0035112) | 2.86321302 |
| 66 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.86320961 |
| 67 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.85267312 |
| 68 | DNA replication-independent nucleosome organization (GO:0034724) | 2.84223735 |
| 69 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.84223735 |
| 70 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.83395134 |
| 71 | anterior/posterior axis specification (GO:0009948) | 2.83338141 |
| 72 | non-recombinational repair (GO:0000726) | 2.82699143 |
| 73 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.82699143 |
| 74 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.81833189 |
| 75 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.80616525 |
| 76 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.80616525 |
| 77 | cell adhesion mediated by integrin (GO:0033627) | 2.79994575 |
| 78 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.79454567 |
| 79 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.79454567 |
| 80 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.79454567 |
| 81 | cellular response to interferon-alpha (GO:0035457) | 2.78723885 |
| 82 | embryonic foregut morphogenesis (GO:0048617) | 2.78208018 |
| 83 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.77425240 |
| 84 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.77425240 |
| 85 | T cell migration (GO:0072678) | 2.77264206 |
| 86 | macrophage activation involved in immune response (GO:0002281) | 2.76251632 |
| 87 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.75927144 |
| 88 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.75927144 |
| 89 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.71740745 |
| 90 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.71738391 |
| 91 | regulation of sulfur metabolic process (GO:0042762) | 2.70460548 |
| 92 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.68912234 |
| 93 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.66622187 |
| 94 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.66311080 |
| 95 | response to peptidoglycan (GO:0032494) | 2.63969025 |
| 96 | protein neddylation (GO:0045116) | 2.63895611 |
| 97 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.63564652 |
| 98 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.63375382 |
| 99 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.63375382 |
| 100 | N-terminal protein amino acid acetylation (GO:0006474) | 2.63128028 |
| 101 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.62969681 |
| 102 | histone mRNA metabolic process (GO:0008334) | 2.62081783 |
| 103 | metaphase plate congression (GO:0051310) | 2.61885705 |
| 104 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.61841880 |
| 105 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.61680699 |
| 106 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.61140209 |
| 107 | gastrulation (GO:0007369) | 2.60579086 |
| 108 | homocysteine metabolic process (GO:0050667) | 2.59244061 |
| 109 | negative regulation of activin receptor signaling pathway (GO:0032926) | 2.58534327 |
| 110 | cullin deneddylation (GO:0010388) | 2.58354252 |
| 111 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.57909459 |
| 112 | response to host immune response (GO:0052572) | 2.57909459 |
| 113 | negative regulation of heart growth (GO:0061117) | 2.57524996 |
| 114 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.57524996 |
| 115 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.56859318 |
| 116 | granulocyte activation (GO:0036230) | 2.56543678 |
| 117 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.56314032 |
| 118 | pinocytosis (GO:0006907) | 2.55642627 |
| 119 | negative regulation of DNA recombination (GO:0045910) | 2.55522719 |
| 120 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043) | 2.54943043 |
| 121 | positive regulation of lamellipodium assembly (GO:0010592) | 2.54383307 |
| 122 | spindle checkpoint (GO:0031577) | 2.53377138 |
| 123 | neutrophil activation (GO:0042119) | 2.53288975 |
| 124 | mitotic metaphase plate congression (GO:0007080) | 2.52982528 |
| 125 | negative regulation of mRNA metabolic process (GO:1903312) | 2.52815292 |
| 126 | negative regulation of ligase activity (GO:0051352) | 2.52783361 |
| 127 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.52783361 |
| 128 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.52745428 |
| 129 | somatic recombination of immunoglobulin gene segments (GO:0016447) | 2.52661271 |
| 130 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.52336908 |
| 131 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.52239599 |
| 132 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.52134420 |
| 133 | response to host (GO:0075136) | 2.52134420 |
| 134 | response to host defenses (GO:0052200) | 2.52134420 |
| 135 | synapsis (GO:0007129) | 2.51463479 |
| 136 | branched-chain amino acid catabolic process (GO:0009083) | 2.50307603 |
| 137 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.49977413 |
| 138 | primitive streak formation (GO:0090009) | 2.49181147 |
| 139 | purine nucleobase biosynthetic process (GO:0009113) | 2.48578212 |
| 140 | embryonic axis specification (GO:0000578) | 2.48552825 |
| 141 | substrate-dependent cell migration (GO:0006929) | 2.47499629 |
| 142 | mitotic spindle checkpoint (GO:0071174) | 2.47285745 |
| 143 | I-kappaB phosphorylation (GO:0007252) | 2.45727159 |
| 144 | immunoglobulin mediated immune response (GO:0016064) | 2.44156910 |
| 145 | positive regulation of interferon-beta production (GO:0032728) | 2.44005310 |
| 146 | response to interferon-alpha (GO:0035455) | 2.43886390 |
| 147 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.42792384 |
| 148 | response to type I interferon (GO:0034340) | 2.42509044 |
| 149 | leukocyte cell-cell adhesion (GO:0007159) | 2.42229413 |
| 150 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.42046964 |
| 151 | growth hormone receptor signaling pathway (GO:0060396) | 2.40182571 |
| 152 | cellular response to type I interferon (GO:0071357) | 2.39639877 |
| 153 | type I interferon signaling pathway (GO:0060337) | 2.39639877 |
| 154 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.39164533 |
| 155 | endodermal cell differentiation (GO:0035987) | 2.37253911 |
| 156 | complement activation, alternative pathway (GO:0006957) | 2.36196873 |
| 157 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.36166447 |
| 158 | cytokine secretion (GO:0050663) | 2.34833121 |
| 159 | positive regulation of T cell chemotaxis (GO:0010820) | 2.34285545 |
| 160 | regulation of T cell chemotaxis (GO:0010819) | 2.34285545 |
| 161 | actin nucleation (GO:0045010) | 2.34202731 |
| 162 | positive regulation of macrophage differentiation (GO:0045651) | 2.33832343 |
| 163 | hippo signaling (GO:0035329) | 2.33162332 |
| 164 | negative regulation of B cell proliferation (GO:0030889) | 2.32254625 |
| 165 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.28021747 |
| 166 | fibrinolysis (GO:0042730) | 2.27972344 |
| 167 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.27963814 |
| 168 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.27679677 |
| 169 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.26747631 |
| 170 | protein carboxylation (GO:0018214) | 2.26747631 |
| 171 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.24598900 |
| 172 | negative thymic T cell selection (GO:0045060) | 2.23997429 |
| 173 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.23624229 |
| 174 | establishment of endothelial barrier (GO:0061028) | 2.22435797 |
| 175 | negative T cell selection (GO:0043383) | 2.22091000 |
| 176 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.20440578 |
| 177 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.20214775 |
| 178 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.17761691 |
| 179 | B cell mediated immunity (GO:0019724) | 2.16779263 |
| 180 | regulation of hypersensitivity (GO:0002883) | 2.15781663 |
| 181 | regulation of B cell differentiation (GO:0045577) | 2.14776228 |
| 182 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.14737533 |
| 183 | regulation of lymphocyte migration (GO:2000401) | 2.14718724 |
| 184 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.14424060 |
| 185 | regulation of T cell tolerance induction (GO:0002664) | 2.14012610 |
| 186 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.13203053 |
| 187 | skin morphogenesis (GO:0043589) | 2.12961282 |
| 188 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.12417676 |
| 189 | alpha-linolenic acid metabolic process (GO:0036109) | 2.11696784 |
| 190 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.11443074 |
| 191 | protein localization to endosome (GO:0036010) | 2.10980030 |
| 192 | positive regulation of blood coagulation (GO:0030194) | 2.10598141 |
| 193 | positive regulation of hemostasis (GO:1900048) | 2.10598141 |
| 194 | regulation of mononuclear cell migration (GO:0071675) | 2.09793032 |
| 195 | integrin-mediated signaling pathway (GO:0007229) | 2.09406488 |
| 196 | heterotypic cell-cell adhesion (GO:0034113) | 2.08655350 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.54214169 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.33807865 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.19339335 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.83178373 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.78760597 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.47140648 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.19302421 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.09674193 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.09615033 |
| 10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.02694926 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.94925425 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.92953662 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.89718298 |
| 14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.86141509 |
| 15 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.68128636 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.64163810 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.60130903 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.58441259 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.48748542 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.43709966 |
| 21 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.41353287 |
| 22 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.41216537 |
| 23 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.40348157 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.38888000 |
| 25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.28133308 |
| 26 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.26327297 |
| 27 | EWS_26573619_Chip-Seq_HEK293_Human | 2.19862613 |
| 28 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.10064677 |
| 29 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.98748944 |
| 30 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.97454575 |
| 31 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.94069481 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.92648247 |
| 33 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.90514316 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.90428114 |
| 35 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.89513796 |
| 36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.88604346 |
| 37 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.85278342 |
| 38 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.82555340 |
| 39 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.82081034 |
| 40 | VDR_22108803_ChIP-Seq_LS180_Human | 1.81770482 |
| 41 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.81025879 |
| 42 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.80177255 |
| 43 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.79957781 |
| 44 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.79474232 |
| 45 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.78589527 |
| 46 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.75759564 |
| 47 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.71887793 |
| 48 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.71812781 |
| 49 | MAF_26560356_Chip-Seq_TH1_Human | 1.69853132 |
| 50 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.68834543 |
| 51 | MYB_26560356_Chip-Seq_TH2_Human | 1.68660523 |
| 52 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.66759642 |
| 53 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.66359387 |
| 54 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.63136338 |
| 55 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.61889226 |
| 56 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.60892014 |
| 57 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.59550570 |
| 58 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.59387491 |
| 59 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.59213927 |
| 60 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.58082913 |
| 61 | FUS_26573619_Chip-Seq_HEK293_Human | 1.57258311 |
| 62 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.53631648 |
| 63 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.52727551 |
| 64 | MYB_26560356_Chip-Seq_TH1_Human | 1.50078455 |
| 65 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.49344239 |
| 66 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.49275311 |
| 67 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.45520973 |
| 68 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.45363594 |
| 69 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.44819193 |
| 70 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.44583169 |
| 71 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.43718984 |
| 72 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.42600635 |
| 73 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.42583068 |
| 74 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.42329744 |
| 75 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.40872985 |
| 76 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.40207968 |
| 77 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.40080513 |
| 78 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.39256955 |
| 79 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.38920283 |
| 80 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.38456460 |
| 81 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.38422092 |
| 82 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.36909527 |
| 83 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.36823619 |
| 84 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.36635864 |
| 85 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.36635864 |
| 86 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.36585103 |
| 87 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.35284014 |
| 88 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.35151202 |
| 89 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.33016690 |
| 90 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.32930274 |
| 91 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31443066 |
| 92 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.30769320 |
| 93 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.30701483 |
| 94 | CJUN_26792858_Chip-Seq_BT549_Human | 1.30555345 |
| 95 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.29437689 |
| 96 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.28881350 |
| 97 | UTX_26944678_Chip-Seq_JUKART_Human | 1.28420813 |
| 98 | GATA1_22025678_ChIP-Seq_K562_Human | 1.28152731 |
| 99 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.28139013 |
| 100 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.27303971 |
| 101 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.24988375 |
| 102 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.24974181 |
| 103 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24024319 |
| 104 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.24017736 |
| 105 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.23604855 |
| 106 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.23081250 |
| 107 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.23081250 |
| 108 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.21457853 |
| 109 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.18402987 |
| 110 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.17971486 |
| 111 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.16866155 |
| 112 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.16700602 |
| 113 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16638343 |
| 114 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.16612097 |
| 115 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.16608311 |
| 116 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.15884734 |
| 117 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14354908 |
| 118 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.13358046 |
| 119 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.13238610 |
| 120 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.12154458 |
| 121 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.12095060 |
| 122 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.12095060 |
| 123 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.12064174 |
| 124 | MYC_22102868_ChIP-Seq_BL_Human | 1.12001383 |
| 125 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.11537718 |
| 126 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10766269 |
| 127 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10306506 |
| 128 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09938939 |
| 129 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.09797346 |
| 130 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.09745652 |
| 131 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09711026 |
| 132 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.08665470 |
| 133 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.07519043 |
| 134 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.07286375 |
| 135 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.07131718 |
| 136 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.06752208 |
| 137 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.06540259 |
| 138 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.06367588 |
| 139 | SPI1_23127762_ChIP-Seq_K562_Human | 1.05796895 |
| 140 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05719916 |
| 141 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.05143849 |
| 142 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.04801086 |
| 143 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.04656678 |
| 144 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04389604 |
| 145 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.03707066 |
| 146 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.03707066 |
| 147 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.03707066 |
| 148 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03566585 |
| 149 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.03427624 |
| 150 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.02856790 |
| 151 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.02562288 |
| 152 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02187671 |
| 153 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.01649549 |
| 154 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01633104 |
| 155 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.01355594 |
| 156 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01047541 |
| 157 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.01015152 |
| 158 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.00671998 |
| 159 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.99983726 |
| 160 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.99926136 |
| 161 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99648814 |
| 162 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99488721 |
| 163 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.98968581 |
| 164 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.97585042 |
| 165 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.96524044 |
| 166 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.96498689 |
| 167 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.95945231 |
| 168 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.95836334 |
| 169 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.95546555 |
| 170 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.95379782 |
| 171 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.93860377 |
| 172 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93422214 |
| 173 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.93303567 |
| 174 | TP53_16413492_ChIP-PET_HCT116_Human | 0.93256630 |
| 175 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.92817606 |
| 176 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91077942 |
| 177 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.90335209 |
| 178 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.88694722 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 4.62977259 |
| 2 | MP0003890_abnormal_embryonic-extraembry | 3.85747994 |
| 3 | MP0003195_calcinosis | 3.59252449 |
| 4 | MP0008057_abnormal_DNA_replication | 3.22211835 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 3.14580514 |
| 6 | MP0003436_decreased_susceptibility_to | 2.89984694 |
| 7 | MP0010352_gastrointestinal_tract_polyps | 2.70256349 |
| 8 | MP0003941_abnormal_skin_development | 2.68693597 |
| 9 | MP0003303_peritoneal_inflammation | 2.64084102 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.54129742 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.52978945 |
| 12 | MP0010094_abnormal_chromosome_stability | 2.46758748 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.38071389 |
| 14 | MP0009785_altered_susceptibility_to | 2.29192358 |
| 15 | MP0006054_spinal_hemorrhage | 2.24891915 |
| 16 | MP0002102_abnormal_ear_morphology | 2.11196762 |
| 17 | MP0004957_abnormal_blastocyst_morpholog | 2.08066941 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.07589147 |
| 19 | MP0005387_immune_system_phenotype | 2.03921689 |
| 20 | MP0001790_abnormal_immune_system | 2.03921689 |
| 21 | MP0006082_CNS_inflammation | 2.00853246 |
| 22 | MP0005275_abnormal_skin_tensile | 1.98910338 |
| 23 | MP0005000_abnormal_immune_tolerance | 1.96038426 |
| 24 | MP0005367_renal/urinary_system_phenotyp | 1.95238483 |
| 25 | MP0000516_abnormal_urinary_system | 1.95238483 |
| 26 | MP0000685_abnormal_immune_system | 1.91475240 |
| 27 | MP0008004_abnormal_stomach_pH | 1.91090950 |
| 28 | MP0002419_abnormal_innate_immunity | 1.87817897 |
| 29 | MP0002139_abnormal_hepatobiliary_system | 1.87448178 |
| 30 | MP0003724_increased_susceptibility_to | 1.87428698 |
| 31 | MP0009697_abnormal_copulation | 1.86967963 |
| 32 | MP0008877_abnormal_DNA_methylation | 1.86558226 |
| 33 | MP0008058_abnormal_DNA_repair | 1.86412803 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 1.85584731 |
| 35 | MP0009053_abnormal_anal_canal | 1.83818022 |
| 36 | MP0003786_premature_aging | 1.83330653 |
| 37 | MP0001800_abnormal_humoral_immune | 1.82892626 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.81920740 |
| 39 | MP0005025_abnormal_response_to | 1.78444499 |
| 40 | MP0002006_tumorigenesis | 1.76273370 |
| 41 | MP0002452_abnormal_antigen_presenting | 1.75949115 |
| 42 | MP0008007_abnormal_cellular_replicative | 1.74811860 |
| 43 | MP0005503_abnormal_tendon_morphology | 1.65784953 |
| 44 | MP0005076_abnormal_cell_differentiation | 1.65154076 |
| 45 | MP0005360_urolithiasis | 1.64863312 |
| 46 | MP0005671_abnormal_response_to | 1.64522958 |
| 47 | MP0004510_myositis | 1.63401802 |
| 48 | MP0000372_irregular_coat_pigmentation | 1.60361897 |
| 49 | MP0002723_abnormal_immune_serum | 1.57410660 |
| 50 | MP0010307_abnormal_tumor_latency | 1.57326573 |
| 51 | MP0003566_abnormal_cell_adhesion | 1.56871543 |
| 52 | MP0004947_skin_inflammation | 1.56194620 |
| 53 | MP0003448_altered_tumor_morphology | 1.55901959 |
| 54 | MP0002138_abnormal_hepatobiliary_system | 1.53232821 |
| 55 | MP0000427_abnormal_hair_cycle | 1.49156066 |
| 56 | MP0010234_abnormal_vibrissa_follicle | 1.46495515 |
| 57 | MP0001819_abnormal_immune_cell | 1.46069788 |
| 58 | MP0005075_abnormal_melanosome_morpholog | 1.45398316 |
| 59 | MP0002420_abnormal_adaptive_immunity | 1.44514031 |
| 60 | MP0003252_abnormal_bile_duct | 1.44068229 |
| 61 | MP0005023_abnormal_wound_healing | 1.43986912 |
| 62 | MP0003806_abnormal_nucleotide_metabolis | 1.42764063 |
| 63 | MP0005464_abnormal_platelet_physiology | 1.41656593 |
| 64 | MP0002933_joint_inflammation | 1.40357503 |
| 65 | MP0008995_early_reproductive_senescence | 1.36858720 |
| 66 | MP0009278_abnormal_bone_marrow | 1.36694333 |
| 67 | MP0010155_abnormal_intestine_physiology | 1.36293942 |
| 68 | MP0004264_abnormal_extraembryonic_tissu | 1.35897277 |
| 69 | MP0000343_altered_response_to | 1.31931548 |
| 70 | MP0003693_abnormal_embryo_hatching | 1.31486496 |
| 71 | MP0003453_abnormal_keratinocyte_physiol | 1.28189836 |
| 72 | MP0004272_abnormal_basement_membrane | 1.27941414 |
| 73 | MP0002405_respiratory_system_inflammati | 1.27109248 |
| 74 | MP0002751_abnormal_autonomic_nervous | 1.26622112 |
| 75 | MP0002277_abnormal_respiratory_mucosa | 1.25884627 |
| 76 | MP0009764_decreased_sensitivity_to | 1.25669633 |
| 77 | MP0001845_abnormal_inflammatory_respons | 1.24128334 |
| 78 | MP0004808_abnormal_hematopoietic_stem | 1.23167186 |
| 79 | MP0003943_abnormal_hepatobiliary_system | 1.23060128 |
| 80 | MP0000733_abnormal_muscle_development | 1.20540623 |
| 81 | MP0009333_abnormal_splenocyte_physiolog | 1.17622012 |
| 82 | MP0003111_abnormal_nucleus_morphology | 1.17026134 |
| 83 | MP0000858_altered_metastatic_potential | 1.16486434 |
| 84 | MP0001545_abnormal_hematopoietic_system | 1.13809287 |
| 85 | MP0005397_hematopoietic_system_phenotyp | 1.13809287 |
| 86 | MP0004484_altered_response_of | 1.13300988 |
| 87 | MP0005390_skeleton_phenotype | 1.13041920 |
| 88 | MP0002398_abnormal_bone_marrow | 1.13018315 |
| 89 | MP0000716_abnormal_immune_system | 1.12180605 |
| 90 | MP0002009_preneoplasia | 1.11863898 |
| 91 | MP0003279_aneurysm | 1.11267319 |
| 92 | MP0000569_abnormal_digit_pigmentation | 1.11000595 |
| 93 | MP0008932_abnormal_embryonic_tissue | 1.09739571 |
| 94 | MP0004215_abnormal_myocardial_fiber | 1.09710913 |
| 95 | MP0009384_cardiac_valve_regurgitation | 1.09110126 |
| 96 | MP0010368_abnormal_lymphatic_system | 1.07626818 |
| 97 | MP0003091_abnormal_cell_migration | 1.07274685 |
| 98 | MP0002998_abnormal_bone_remodeling | 1.07079653 |
| 99 | MP0005085_abnormal_gallbladder_physiolo | 1.06178779 |
| 100 | MP0009840_abnormal_foam_cell | 1.05669804 |
| 101 | MP0001853_heart_inflammation | 1.05611075 |
| 102 | MP0008469_abnormal_protein_level | 1.03726187 |
| 103 | MP0003119_abnormal_digestive_system | 1.03651711 |
| 104 | MP0003077_abnormal_cell_cycle | 1.03001852 |
| 105 | MP0003191_abnormal_cellular_cholesterol | 1.02486063 |
| 106 | MP0000767_abnormal_smooth_muscle | 1.02386079 |
| 107 | MP0001666_abnormal_nutrient_absorption | 1.01201886 |
| 108 | MP0003828_pulmonary_edema | 1.01160841 |
| 109 | MP0005248_abnormal_Harderian_gland | 0.96539529 |
| 110 | MP0001243_abnormal_dermal_layer | 0.94831484 |
| 111 | MP0000689_abnormal_spleen_morphology | 0.93233530 |
| 112 | MP0002837_dystrophic_cardiac_calcinosis | 0.92312410 |
| 113 | MP0002722_abnormal_immune_system | 0.91847021 |
| 114 | MP0005380_embryogenesis_phenotype | 0.90557519 |
| 115 | MP0001672_abnormal_embryogenesis/_devel | 0.90557519 |
| 116 | MP0000465_gastrointestinal_hemorrhage | 0.89561186 |
| 117 | MP0001915_intracranial_hemorrhage | 0.89506934 |
| 118 | MP0002429_abnormal_blood_cell | 0.89472059 |
| 119 | MP0001727_abnormal_embryo_implantation | 0.89022387 |
| 120 | MP0001851_eye_inflammation | 0.88492860 |
| 121 | MP0002060_abnormal_skin_morphology | 0.88467619 |
| 122 | MP0000249_abnormal_blood_vessel | 0.88055837 |
| 123 | MP0002090_abnormal_vision | 0.87915174 |
| 124 | MP0005164_abnormal_response_to | 0.87814932 |
| 125 | MP0001697_abnormal_embryo_size | 0.86866754 |
| 126 | MP0000377_abnormal_hair_follicle | 0.86612598 |
| 127 | MP0003763_abnormal_thymus_physiology | 0.85997616 |
| 128 | MP0005084_abnormal_gallbladder_morpholo | 0.85748582 |
| 129 | MP0003221_abnormal_cardiomyocyte_apopto | 0.85704755 |
| 130 | MP0004185_abnormal_adipocyte_glucose | 0.85219414 |
| 131 | MP0002396_abnormal_hematopoietic_system | 0.84826427 |
| 132 | MP0002088_abnormal_embryonic_growth/wei | 0.84315386 |
| 133 | MP0001873_stomach_inflammation | 0.84293669 |
| 134 | MP0003186_abnormal_redox_activity | 0.84090866 |
| 135 | MP0003937_abnormal_limbs/digits/tail_de | 0.83915533 |
| 136 | MP0001879_abnormal_lymphatic_vessel | 0.82781375 |
| 137 | MP0000609_abnormal_liver_physiology | 0.82495156 |
| 138 | MP0001119_abnormal_female_reproductive | 0.80695586 |
| 139 | MP0010678_abnormal_skin_adnexa | 0.80203689 |
| 140 | MP0009763_increased_sensitivity_to | 0.80118393 |
| 141 | MP0001216_abnormal_epidermal_layer | 0.79014671 |
| 142 | MP0006035_abnormal_mitochondrial_morpho | 0.78859546 |
| 143 | MP0001485_abnormal_pinna_reflex | 0.78850103 |
| 144 | MP0003656_abnormal_erythrocyte_physiolo | 0.78703640 |
| 145 | MP0003567_abnormal_fetal_cardiomyocyte | 0.77970247 |
| 146 | MP0002168_other_aberrant_phenotype | 0.77757992 |
| 147 | MP0006036_abnormal_mitochondrial_physio | 0.77200059 |
| 148 | MP0005365_abnormal_bile_salt | 0.76720749 |
| 149 | MP0002282_abnormal_trachea_morphology | 0.76574627 |
| 150 | MP0003984_embryonic_growth_retardation | 0.76233912 |
| 151 | MP0005058_abnormal_lysosome_morphology | 0.76000312 |
| 152 | MP0000647_abnormal_sebaceous_gland | 0.75352550 |
| 153 | MP0000604_amyloidosis | 0.74701932 |
| 154 | MP0004883_abnormal_blood_vessel | 0.73797847 |
| 155 | MP0002128_abnormal_blood_circulation | 0.73236692 |
| 156 | MP0005647_abnormal_sex_gland | 0.71387635 |
| 157 | MP0001730_embryonic_growth_arrest | 0.70181265 |
| 158 | MP0000383_abnormal_hair_follicle | 0.69011848 |
| 159 | MP0002084_abnormal_developmental_patter | 0.68563081 |
| 160 | MP0005395_other_phenotype | 0.68219356 |
| 161 | MP0000358_abnormal_cell_content/ | 0.66973718 |
| 162 | MP0005220_abnormal_exocrine_pancreas | 0.65603366 |
| 163 | MP0000538_abnormal_urinary_bladder | 0.64851696 |
| 164 | MP0001177_atelectasis | 0.64824923 |
| 165 | MP0005310_abnormal_salivary_gland | 0.62808262 |
| 166 | MP0008872_abnormal_physiological_respon | 0.62785004 |
| 167 | MP0002086_abnormal_extraembryonic_tissu | 0.62725057 |
| 168 | MP0002127_abnormal_cardiovascular_syste | 0.61839259 |
| 169 | MP0001293_anophthalmia | 0.61163549 |
| 170 | MP0001984_abnormal_olfaction | 0.60401475 |
| 171 | MP0002132_abnormal_respiratory_system | 0.59994426 |
| 172 | MP0000350_abnormal_cell_proliferation | 0.59823720 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.32459496 |
| 2 | Recurrent abscess formation (HP:0002722) | 3.82459508 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 3.81423534 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.66826432 |
| 5 | Abnormality of chromosome stability (HP:0003220) | 3.36701320 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 3.30042423 |
| 7 | Rhabdomyosarcoma (HP:0002859) | 3.19813166 |
| 8 | Protrusio acetabuli (HP:0003179) | 3.17647778 |
| 9 | Abnormality of methionine metabolism (HP:0010901) | 3.13972394 |
| 10 | Autoimmune thrombocytopenia (HP:0001973) | 3.13713269 |
| 11 | Thyroiditis (HP:0100646) | 3.09707967 |
| 12 | B lymphocytopenia (HP:0010976) | 3.09688898 |
| 13 | Abnormal umbilical cord blood vessels (HP:0011403) | 3.06923591 |
| 14 | Single umbilical artery (HP:0001195) | 3.06923591 |
| 15 | Abnormality of the fetal cardiovascular system (HP:0010948) | 3.06923591 |
| 16 | Abnormality of B cell number (HP:0010975) | 3.06125467 |
| 17 | Methylmalonic acidemia (HP:0002912) | 3.01379110 |
| 18 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.00187913 |
| 19 | Myocardial infarction (HP:0001658) | 3.00135110 |
| 20 | Breast carcinoma (HP:0003002) | 2.97264255 |
| 21 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.94841967 |
| 22 | Osteolytic defects of the hand bones (HP:0009699) | 2.94841967 |
| 23 | Volvulus (HP:0002580) | 2.92134371 |
| 24 | Hematochezia (HP:0002573) | 2.81318161 |
| 25 | Progressive inability to walk (HP:0002505) | 2.80439909 |
| 26 | Spontaneous hematomas (HP:0007420) | 2.78657420 |
| 27 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.78148624 |
| 28 | Disinhibition (HP:0000734) | 2.73831183 |
| 29 | Complement deficiency (HP:0004431) | 2.68250534 |
| 30 | Peritonitis (HP:0002586) | 2.67641505 |
| 31 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.67480024 |
| 32 | Glomerulonephritis (HP:0000099) | 2.67041438 |
| 33 | Abnormality of the parathyroid morphology (HP:0011766) | 2.62834776 |
| 34 | Intestinal atresia (HP:0011100) | 2.62680149 |
| 35 | Thick nail (HP:0001805) | 2.62203300 |
| 36 | Axonal loss (HP:0003447) | 2.61139907 |
| 37 | Ependymoma (HP:0002888) | 2.58855538 |
| 38 | Premature rupture of membranes (HP:0001788) | 2.58296674 |
| 39 | Chromsome breakage (HP:0040012) | 2.56731008 |
| 40 | Curly hair (HP:0002212) | 2.53620518 |
| 41 | Glioma (HP:0009733) | 2.52209234 |
| 42 | Abnormal lung lobation (HP:0002101) | 2.51256313 |
| 43 | Neoplasm of the adrenal gland (HP:0100631) | 2.49969903 |
| 44 | Double outlet right ventricle (HP:0001719) | 2.48976216 |
| 45 | Congenital malformation of the right heart (HP:0011723) | 2.48976216 |
| 46 | Syringomyelia (HP:0003396) | 2.48670767 |
| 47 | Spinal cord lesions (HP:0100561) | 2.48670767 |
| 48 | Papilledema (HP:0001085) | 2.48535705 |
| 49 | Aqueductal stenosis (HP:0002410) | 2.48104029 |
| 50 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.48036246 |
| 51 | Stomatitis (HP:0010280) | 2.46701608 |
| 52 | Deep venous thrombosis (HP:0002625) | 2.44008633 |
| 53 | Recurrent viral infections (HP:0004429) | 2.43787247 |
| 54 | Abnormality of the umbilical cord (HP:0010881) | 2.43283534 |
| 55 | Meckel diverticulum (HP:0002245) | 2.42556101 |
| 56 | Subacute progressive viral hepatitis (HP:0006572) | 2.42513250 |
| 57 | Abnormality of vitamin B metabolism (HP:0004340) | 2.41150634 |
| 58 | Gonadotropin excess (HP:0000837) | 2.37784196 |
| 59 | Hypothermia (HP:0002045) | 2.34853964 |
| 60 | Mediastinal lymphadenopathy (HP:0100721) | 2.34712641 |
| 61 | Aortic dissection (HP:0002647) | 2.31252062 |
| 62 | Abnormality of macrophages (HP:0004311) | 2.31136278 |
| 63 | Abnormality of the astrocytes (HP:0100707) | 2.30012661 |
| 64 | Astrocytoma (HP:0009592) | 2.30012661 |
| 65 | Hypoproteinemia (HP:0003075) | 2.29962656 |
| 66 | Ankle contracture (HP:0006466) | 2.29921233 |
| 67 | Abnormality of the ileum (HP:0001549) | 2.29798215 |
| 68 | Hypoplastic pelvis (HP:0008839) | 2.29427181 |
| 69 | Gastrointestinal infarctions (HP:0005244) | 2.28280318 |
| 70 | Short 4th metacarpal (HP:0010044) | 2.27758608 |
| 71 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.27758608 |
| 72 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.27610269 |
| 73 | Myositis (HP:0100614) | 2.27484556 |
| 74 | Abnormality of the preputium (HP:0100587) | 2.27471200 |
| 75 | Recurrent skin infections (HP:0001581) | 2.27353824 |
| 76 | Recurrent fungal infections (HP:0002841) | 2.26975463 |
| 77 | Abnormality of T cell number (HP:0011839) | 2.25157528 |
| 78 | Gingival bleeding (HP:0000225) | 2.22563189 |
| 79 | Cellulitis (HP:0100658) | 2.22526869 |
| 80 | Meningioma (HP:0002858) | 2.21791919 |
| 81 | Vertebral compression fractures (HP:0002953) | 2.19809123 |
| 82 | Embryonal renal neoplasm (HP:0011794) | 2.19764856 |
| 83 | Spondylolisthesis (HP:0003302) | 2.19544346 |
| 84 | Abnormality of complement system (HP:0005339) | 2.18956663 |
| 85 | Severe combined immunodeficiency (HP:0004430) | 2.18708617 |
| 86 | Asymmetry of the thorax (HP:0001555) | 2.18185515 |
| 87 | Ovarian neoplasm (HP:0100615) | 2.18178253 |
| 88 | Facial diplegia (HP:0001349) | 2.17986459 |
| 89 | Abnormality of the common coagulation pathway (HP:0010990) | 2.17832062 |
| 90 | Symptomatic seizures (HP:0011145) | 2.17268359 |
| 91 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.17211428 |
| 92 | Combined immunodeficiency (HP:0005387) | 2.16496671 |
| 93 | Increased density of long bones (HP:0006392) | 2.15146185 |
| 94 | Mitral valve prolapse (HP:0001634) | 2.15061117 |
| 95 | T lymphocytopenia (HP:0005403) | 2.15020694 |
| 96 | Hamartoma of the eye (HP:0010568) | 2.12894407 |
| 97 | Increased cerebral lipofuscin (HP:0011813) | 2.12587497 |
| 98 | Disproportionate short-trunk short stature (HP:0003521) | 2.12266105 |
| 99 | Chronic obstructive pulmonary disease (HP:0006510) | 2.10423633 |
| 100 | Obstructive lung disease (HP:0006536) | 2.10423633 |
| 101 | Gingivitis (HP:0000230) | 2.10380524 |
| 102 | Short middle phalanx of the 5th finger (HP:0004220) | 2.09816166 |
| 103 | Shallow orbits (HP:0000586) | 2.09312446 |
| 104 | Abnormal pancreas size (HP:0012094) | 2.09241448 |
| 105 | Abnormal platelet volume (HP:0011876) | 2.08970817 |
| 106 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.08729935 |
| 107 | Increased mean platelet volume (HP:0011877) | 2.07790829 |
| 108 | Aortic aneurysm (HP:0004942) | 2.07639220 |
| 109 | Anal stenosis (HP:0002025) | 2.07039542 |
| 110 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.05780536 |
| 111 | Abnormality of the lumbar spine (HP:0100712) | 2.05761789 |
| 112 | Urticaria (HP:0001025) | 2.05180856 |
| 113 | Nephritis (HP:0000123) | 2.04109571 |
| 114 | Mitral stenosis (HP:0001718) | 2.03306517 |
| 115 | Xanthomatosis (HP:0000991) | 2.02972979 |
| 116 | Abdominal situs inversus (HP:0003363) | 2.01902492 |
| 117 | Abnormality of abdominal situs (HP:0011620) | 2.01902492 |
| 118 | Esophageal varix (HP:0002040) | 2.01740366 |
| 119 | Vasculitis (HP:0002633) | 2.01228455 |
| 120 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.01137141 |
| 121 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.00978069 |
| 122 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.00978069 |
| 123 | Neoplasm of the adrenal cortex (HP:0100641) | 2.00613499 |
| 124 | Hypobetalipoproteinemia (HP:0003563) | 1.99491282 |
| 125 | Dyschromatopsia (HP:0007641) | 1.99336848 |
| 126 | Abnormality of the duodenum (HP:0002246) | 1.99199283 |
| 127 | Methylmalonic aciduria (HP:0012120) | 1.99082936 |
| 128 | Pustule (HP:0200039) | 1.98827199 |
| 129 | Hypoglycemic seizures (HP:0002173) | 1.98064394 |
| 130 | Gonadal dysgenesis (HP:0000133) | 1.96800429 |
| 131 | Osteomyelitis (HP:0002754) | 1.96057977 |
| 132 | Abnormal hair whorl (HP:0010721) | 1.95251685 |
| 133 | Colon cancer (HP:0003003) | 1.93922898 |
| 134 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.93335346 |
| 135 | Agnosia (HP:0010524) | 1.91592939 |
| 136 | Periodontitis (HP:0000704) | 1.91293903 |
| 137 | Arterial thrombosis (HP:0004420) | 1.91061279 |
| 138 | Abnormality of the 4th metacarpal (HP:0010012) | 1.89866897 |
| 139 | Bifid tongue (HP:0010297) | 1.89608514 |
| 140 | Posterior subcapsular cataract (HP:0007787) | 1.89577631 |
| 141 | Clubbing of toes (HP:0100760) | 1.89569760 |
| 142 | Bladder carcinoma (HP:0002862) | 1.89014426 |
| 143 | Bladder neoplasm (HP:0009725) | 1.89014426 |
| 144 | Dilatation of the ascending aorta (HP:0005111) | 1.89000672 |
| 145 | Conjunctival hamartoma (HP:0100780) | 1.87905984 |
| 146 | Intrahepatic cholestasis (HP:0001406) | 1.86538603 |
| 147 | Uterine neoplasm (HP:0010784) | 1.86109481 |
| 148 | Neoplasm of striated muscle (HP:0009728) | 1.83847935 |
| 149 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.82856525 |
| 150 | Sensory axonal neuropathy (HP:0003390) | 1.82723561 |
| 151 | Duodenal stenosis (HP:0100867) | 1.82254412 |
| 152 | Small intestinal stenosis (HP:0012848) | 1.82254412 |
| 153 | Disproportionate tall stature (HP:0001519) | 1.82188545 |
| 154 | Hypolipoproteinemia (HP:0010981) | 1.82060193 |
| 155 | Cerebral aneurysm (HP:0004944) | 1.81788286 |
| 156 | Abnormality of homocysteine metabolism (HP:0010919) | 1.80761249 |
| 157 | Homocystinuria (HP:0002156) | 1.80761249 |
| 158 | Basal ganglia calcification (HP:0002135) | 1.79895836 |
| 159 | Broad metatarsal (HP:0001783) | 1.79701930 |
| 160 | Absent frontal sinuses (HP:0002688) | 1.79362061 |
| 161 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.79252667 |
| 162 | Cutaneous melanoma (HP:0012056) | 1.78566631 |
| 163 | Orchitis (HP:0100796) | 1.78237825 |
| 164 | Asplenia (HP:0001746) | 1.77412981 |
| 165 | Leukocytosis (HP:0001974) | 1.76860759 |
| 166 | Tongue fasciculations (HP:0001308) | 1.76687234 |
| 167 | Hemorrhage of the eye (HP:0011885) | 1.75544135 |
| 168 | Eosinophilia (HP:0001880) | 1.74448695 |
| 169 | Blue sclerae (HP:0000592) | 1.74386463 |
| 170 | Increased IgE level (HP:0003212) | 1.74215771 |
| 171 | Pulmonary embolism (HP:0002204) | 1.73409165 |
| 172 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.70918099 |
| 173 | Persistence of primary teeth (HP:0006335) | 1.70785174 |
| 174 | Interstitial pulmonary disease (HP:0006530) | 1.70189906 |
| 175 | Angiofibromas (HP:0010615) | 1.69915582 |
| 176 | Adenoma sebaceum (HP:0009720) | 1.69915582 |
| 177 | Biliary tract neoplasm (HP:0100574) | 1.68547734 |
| 178 | Multiple enchondromatosis (HP:0005701) | 1.67899381 |
| 179 | Abnormality of serum amino acid levels (HP:0003112) | 1.67148809 |
| 180 | Abolished electroretinogram (ERG) (HP:0000550) | 1.66924229 |
| 181 | Septo-optic dysplasia (HP:0100842) | 1.66727738 |
| 182 | Amyloidosis (HP:0011034) | 1.66492680 |
| 183 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.66441625 |
| 184 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.66194654 |
| 185 | Mucosal telangiectasiae (HP:0100579) | 1.65690714 |
| 186 | Cervical subluxation (HP:0003308) | 1.65176096 |
| 187 | Hypercholesterolemia (HP:0003124) | 1.64446806 |
| 188 | Rectal prolapse (HP:0002035) | 1.64195670 |
| 189 | Exercise-induced muscle cramps (HP:0003710) | 1.62777812 |
| 190 | Chronic otitis media (HP:0000389) | 1.62730288 |
| 191 | Frequent falls (HP:0002359) | 1.62673333 |
| 192 | Abnormality of the peritoneum (HP:0002585) | 1.62099153 |
| 193 | Narrow palate (HP:0000189) | 1.61338222 |
| 194 | Camptodactyly of toe (HP:0001836) | 1.60831048 |
| 195 | Arterial tortuosity (HP:0005116) | 1.60739240 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28 | 5.20096363 |
| 2 | SIK3 | 4.25169796 |
| 3 | EIF2AK3 | 3.75958389 |
| 4 | MKNK2 | 3.46352737 |
| 5 | BMPR1B | 2.61186668 |
| 6 | MAP3K14 | 2.54016242 |
| 7 | MAP3K10 | 2.46044450 |
| 8 | STK3 | 2.42718596 |
| 9 | TNIK | 2.40654089 |
| 10 | MAP4K1 | 2.40545240 |
| 11 | EIF2AK1 | 2.35914553 |
| 12 | WNK3 | 2.35883402 |
| 13 | MKNK1 | 2.30415014 |
| 14 | STK10 | 2.30108740 |
| 15 | NME2 | 2.24651845 |
| 16 | TYK2 | 2.22352401 |
| 17 | TXK | 2.10233901 |
| 18 | FGFR3 | 2.06016221 |
| 19 | TBK1 | 2.03003690 |
| 20 | CSF1R | 1.98074220 |
| 21 | NEK9 | 1.95406898 |
| 22 | EPHB1 | 1.91724167 |
| 23 | PKN2 | 1.91591742 |
| 24 | ERN1 | 1.85965225 |
| 25 | JAK1 | 1.84135607 |
| 26 | BCR | 1.82595341 |
| 27 | CDK6 | 1.81233750 |
| 28 | EPHA3 | 1.79680047 |
| 29 | FGFR4 | 1.78623651 |
| 30 | MAP4K2 | 1.77159031 |
| 31 | BUB1 | 1.77118241 |
| 32 | PLK3 | 1.74044315 |
| 33 | CSK | 1.72903530 |
| 34 | LRRK2 | 1.65175358 |
| 35 | IKBKE | 1.58016930 |
| 36 | TGFBR2 | 1.57031697 |
| 37 | JAK3 | 1.56794273 |
| 38 | IRAK4 | 1.54795257 |
| 39 | LATS1 | 1.52042496 |
| 40 | RPS6KA4 | 1.51325938 |
| 41 | BRSK2 | 1.49266033 |
| 42 | ITK | 1.45530672 |
| 43 | EPHB2 | 1.43281675 |
| 44 | BLK | 1.42071829 |
| 45 | ACVR1B | 1.41370755 |
| 46 | TRIB3 | 1.38090433 |
| 47 | HCK | 1.36923785 |
| 48 | ZAP70 | 1.36623806 |
| 49 | PLK4 | 1.35448975 |
| 50 | PIK3CG | 1.32192435 |
| 51 | MAP3K12 | 1.31803866 |
| 52 | PLK2 | 1.31057607 |
| 53 | TTN | 1.28776703 |
| 54 | CAMK1D | 1.27417852 |
| 55 | IKBKB | 1.26934843 |
| 56 | EEF2K | 1.23494220 |
| 57 | DMPK | 1.22788607 |
| 58 | PTK6 | 1.20569141 |
| 59 | TSSK6 | 1.19150870 |
| 60 | TAF1 | 1.14270358 |
| 61 | ERBB4 | 1.13784193 |
| 62 | STK38L | 1.13740417 |
| 63 | EIF2AK2 | 1.13256330 |
| 64 | STK39 | 1.11540547 |
| 65 | SIK1 | 1.10167622 |
| 66 | TTK | 1.07767996 |
| 67 | ERBB3 | 1.04017800 |
| 68 | TRPM7 | 1.02270871 |
| 69 | SRPK1 | 1.01537110 |
| 70 | CHUK | 1.00520778 |
| 71 | STK4 | 0.99696457 |
| 72 | LCK | 0.98672832 |
| 73 | GRK1 | 0.97426800 |
| 74 | MAP3K3 | 0.97249548 |
| 75 | FER | 0.95754861 |
| 76 | OXSR1 | 0.95011227 |
| 77 | BTK | 0.94964556 |
| 78 | KIT | 0.94099267 |
| 79 | PIM2 | 0.91286091 |
| 80 | CLK1 | 0.90170278 |
| 81 | MAP2K3 | 0.89818401 |
| 82 | TEC | 0.89519702 |
| 83 | TGFBR1 | 0.89448581 |
| 84 | FRK | 0.88486521 |
| 85 | MARK3 | 0.88156669 |
| 86 | PBK | 0.86643743 |
| 87 | SYK | 0.85829944 |
| 88 | NUAK1 | 0.85718556 |
| 89 | RIPK4 | 0.85401826 |
| 90 | CAMK1G | 0.84573629 |
| 91 | PIM1 | 0.83638770 |
| 92 | FGFR1 | 0.83521705 |
| 93 | WEE1 | 0.82880487 |
| 94 | JAK2 | 0.82665281 |
| 95 | BMX | 0.80865404 |
| 96 | RIPK1 | 0.79482207 |
| 97 | STK24 | 0.79282243 |
| 98 | EGFR | 0.78700183 |
| 99 | FGFR2 | 0.75834496 |
| 100 | NEK1 | 0.74485192 |
| 101 | PRKCQ | 0.74201597 |
| 102 | VRK2 | 0.73169336 |
| 103 | MELK | 0.72734103 |
| 104 | MST4 | 0.69900469 |
| 105 | ZAK | 0.68189497 |
| 106 | KDR | 0.67041920 |
| 107 | KSR1 | 0.66938195 |
| 108 | PDGFRB | 0.66698316 |
| 109 | MAP3K5 | 0.65991132 |
| 110 | YES1 | 0.65950266 |
| 111 | LYN | 0.65906717 |
| 112 | SCYL2 | 0.64159552 |
| 113 | ABL1 | 0.64064039 |
| 114 | PAK3 | 0.63729284 |
| 115 | PLK1 | 0.62650427 |
| 116 | FLT3 | 0.62587261 |
| 117 | BMPR2 | 0.61973795 |
| 118 | IRAK2 | 0.61737727 |
| 119 | BRD4 | 0.61143956 |
| 120 | ALK | 0.60370388 |
| 121 | PAK4 | 0.60165107 |
| 122 | PAK2 | 0.59443240 |
| 123 | PDGFRA | 0.59404559 |
| 124 | DDR2 | 0.58698350 |
| 125 | CDK12 | 0.58452619 |
| 126 | IRAK1 | 0.56792955 |
| 127 | FES | 0.56377786 |
| 128 | MAPKAPK2 | 0.55119161 |
| 129 | MUSK | 0.54590414 |
| 130 | IGF1R | 0.53888109 |
| 131 | MAP3K8 | 0.52229309 |
| 132 | ADRBK2 | 0.52019220 |
| 133 | CDK4 | 0.50811456 |
| 134 | FYN | 0.49644437 |
| 135 | DYRK1B | 0.49165737 |
| 136 | CSNK1G1 | 0.49097791 |
| 137 | GSK3A | 0.48980179 |
| 138 | NLK | 0.48386825 |
| 139 | PDK2 | 0.48314323 |
| 140 | INSR | 0.47600956 |
| 141 | VRK1 | 0.46984402 |
| 142 | ABL2 | 0.46279900 |
| 143 | RPS6KB2 | 0.45453446 |
| 144 | GRK6 | 0.42718772 |
| 145 | MAP3K13 | 0.42548664 |
| 146 | AKT3 | 0.42411842 |
| 147 | IRAK3 | 0.41729608 |
| 148 | MAPK4 | 0.41188942 |
| 149 | GRK7 | 0.39842376 |
| 150 | FGR | 0.36413884 |
| 151 | PRKCI | 0.34320185 |
| 152 | ROCK2 | 0.33401338 |
| 153 | PRKCE | 0.32176442 |
| 154 | ATM | 0.31658658 |
| 155 | MAPK13 | 0.30613559 |
| 156 | DYRK3 | 0.29499070 |
| 157 | PASK | 0.29301969 |
| 158 | PIK3CA | 0.28537662 |
| 159 | MINK1 | 0.24757306 |
| 160 | ROCK1 | 0.22921142 |
| 161 | CDC7 | 0.22496346 |
| 162 | CSNK1G2 | 0.22109951 |
| 163 | ADRBK1 | 0.21547029 |
| 164 | BRSK1 | 0.21476673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.82115371 |
| 2 | Non-homologous end-joining_Homo sapiens_hsa03450 | 3.62768945 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.59344127 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.16544567 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.69353401 |
| 6 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.68418032 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.61744149 |
| 8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.36430717 |
| 9 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.34301792 |
| 10 | Basal transcription factors_Homo sapiens_hsa03022 | 2.14178748 |
| 11 | RNA degradation_Homo sapiens_hsa03018 | 2.11732710 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 2.10093324 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.09338775 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.05289493 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.01358675 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.99624099 |
| 17 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.99012450 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.97689250 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.93712152 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.90228928 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.85352680 |
| 22 | RNA transport_Homo sapiens_hsa03013 | 1.80667915 |
| 23 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.80440639 |
| 24 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.77921039 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.74846497 |
| 26 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.74440753 |
| 27 | Allograft rejection_Homo sapiens_hsa05330 | 1.66415492 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.65914182 |
| 29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.65767280 |
| 30 | Measles_Homo sapiens_hsa05162 | 1.65656307 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.64524561 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.63717438 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.63443833 |
| 34 | Mismatch repair_Homo sapiens_hsa03430 | 1.61193226 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56937569 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.56528909 |
| 37 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.55592700 |
| 38 | Legionellosis_Homo sapiens_hsa05134 | 1.54943213 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.49382485 |
| 40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.46942484 |
| 41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.45235659 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.44358163 |
| 43 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.42141920 |
| 44 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.39276234 |
| 45 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.37891896 |
| 46 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.37627376 |
| 47 | Tuberculosis_Homo sapiens_hsa05152 | 1.36691927 |
| 48 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.34323349 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.33932282 |
| 50 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.33301343 |
| 51 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.33127322 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.31352385 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.31057169 |
| 54 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.29344348 |
| 55 | Hepatitis B_Homo sapiens_hsa05161 | 1.28862207 |
| 56 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.27890021 |
| 57 | Cell cycle_Homo sapiens_hsa04110 | 1.27745270 |
| 58 | Shigellosis_Homo sapiens_hsa05131 | 1.25302678 |
| 59 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.25263945 |
| 60 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.25117841 |
| 61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.24071365 |
| 62 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.23030840 |
| 63 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.22261532 |
| 64 | Influenza A_Homo sapiens_hsa05164 | 1.19765714 |
| 65 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.19170527 |
| 66 | Salmonella infection_Homo sapiens_hsa05132 | 1.17577523 |
| 67 | Amoebiasis_Homo sapiens_hsa05146 | 1.17125670 |
| 68 | Adherens junction_Homo sapiens_hsa04520 | 1.16142767 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.13219411 |
| 70 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13116554 |
| 71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.13018628 |
| 72 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.12306431 |
| 73 | Platelet activation_Homo sapiens_hsa04611 | 1.11960964 |
| 74 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.11504897 |
| 75 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.09714623 |
| 76 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.09367623 |
| 77 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.09227796 |
| 78 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.09101629 |
| 79 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.03286397 |
| 80 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.02691445 |
| 81 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.01350379 |
| 82 | Apoptosis_Homo sapiens_hsa04210 | 0.97507345 |
| 83 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.97295778 |
| 84 | Focal adhesion_Homo sapiens_hsa04510 | 0.97138466 |
| 85 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.95580359 |
| 86 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.93381996 |
| 87 | Peroxisome_Homo sapiens_hsa04146 | 0.92922144 |
| 88 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.92162884 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.89687353 |
| 90 | Asthma_Homo sapiens_hsa05310 | 0.89566387 |
| 91 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.87528934 |
| 92 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.86875502 |
| 93 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.86394090 |
| 94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.85630487 |
| 95 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.84831346 |
| 96 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.84770363 |
| 97 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.83576677 |
| 98 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.82991917 |
| 99 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.81920098 |
| 100 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.81693634 |
| 101 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.80093526 |
| 102 | Prostate cancer_Homo sapiens_hsa05215 | 0.78771193 |
| 103 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.77647859 |
| 104 | Lysine degradation_Homo sapiens_hsa00310 | 0.76374433 |
| 105 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.75281729 |
| 106 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.75262094 |
| 107 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.74891332 |
| 108 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.73928874 |
| 109 | RNA polymerase_Homo sapiens_hsa03020 | 0.73789514 |
| 110 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.72328570 |
| 111 | Insulin resistance_Homo sapiens_hsa04931 | 0.72103535 |
| 112 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.71347384 |
| 113 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70962497 |
| 114 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.70406193 |
| 115 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.69052969 |
| 116 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.67449252 |
| 117 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.67171963 |
| 118 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.66603704 |
| 119 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.66388530 |
| 120 | Phagosome_Homo sapiens_hsa04145 | 0.66010499 |
| 121 | HTLV-I infection_Homo sapiens_hsa05166 | 0.65728713 |
| 122 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65629500 |
| 123 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.65328703 |
| 124 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61772600 |
| 125 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.61392316 |
| 126 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61044354 |
| 127 | Retinol metabolism_Homo sapiens_hsa00830 | 0.60232498 |
| 128 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.58673027 |
| 129 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.57178064 |
| 130 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.56802859 |
| 131 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54146872 |
| 132 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54031169 |
| 133 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53172350 |
| 134 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52498418 |
| 135 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51814536 |
| 136 | Colorectal cancer_Homo sapiens_hsa05210 | 0.51569422 |
| 137 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.51293897 |
| 138 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.50568872 |
| 139 | Pathways in cancer_Homo sapiens_hsa05200 | 0.49610246 |
| 140 | Spliceosome_Homo sapiens_hsa03040 | 0.49247958 |
| 141 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.47317540 |
| 142 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.47007005 |
| 143 | DNA replication_Homo sapiens_hsa03030 | 0.46578348 |
| 144 | Bladder cancer_Homo sapiens_hsa05219 | 0.46565754 |
| 145 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.45932459 |
| 146 | Lysosome_Homo sapiens_hsa04142 | 0.44893875 |
| 147 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44884816 |
| 148 | Glioma_Homo sapiens_hsa05214 | 0.43417594 |
| 149 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43196133 |
| 150 | Endocytosis_Homo sapiens_hsa04144 | 0.42282570 |
| 151 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41432067 |
| 152 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.41191731 |
| 153 | Thyroid cancer_Homo sapiens_hsa05216 | 0.41026149 |
| 154 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.40864743 |
| 155 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.39553303 |
| 156 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.38199278 |
| 157 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.38191001 |
| 158 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37088817 |
| 159 | Endometrial cancer_Homo sapiens_hsa05213 | 0.36949640 |
| 160 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.36705000 |
| 161 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.35175550 |
| 162 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.34712932 |
| 163 | Purine metabolism_Homo sapiens_hsa00230 | 0.33944002 |
| 164 | Circadian rhythm_Homo sapiens_hsa04710 | 0.32521062 |
| 165 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30637088 |
| 166 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.30293693 |

